drugs with semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Oral Semaglutide for Weight Loss
Description
By simulating the effects of the GLP-1 hormone, semaglutide helps reduce appetite and assists in achieving significant, sustainable weight loss
Steady progress that feels sustainable and empowering
In the SURMOUNT 1 trial, tirzepatide 15 mg/wk with general nutritional instructions produced a 20.9 % reduction in body weight from baseline (versus 3.1 % with general nutrition instructions alone) [15], whereas in the SURMOUNT 3 trial, tirzepatide 10 or 15 mg/wk started after 12 weeks of intensive lifestyle intervention produced a 25 % reduction from baseline (versus 4.8 % with intensive lifestyle intervention alone) [170]
Tirzepatide offers enhanced weight loss potential through its unique dual-action mechanism: Dual Hormone Activation : Tirzepatide works on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, providing superior appetite control and metabolic benefits compared to single-action medications
Zinman B, Bhosekar V, Busch R, Holst I, Ludvik B, Thielke D, Thrasher J, Woo V, Philis-Tsimikas A
Blonde L, Pencek R, Macconell L
